293 related articles for article (PubMed ID: 22535850)
1. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
[No Abstract] [Full Text] [Related]
2. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
Schröder FH
N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
[No Abstract] [Full Text] [Related]
3. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
Brett AS; Ablin RJ
N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
[No Abstract] [Full Text] [Related]
4. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
Volk RJ; Wolf AM
JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
[No Abstract] [Full Text] [Related]
5. New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
Wroclawski ML
Einstein (Sao Paulo); 2017; 15(3):7-10. PubMed ID: 29091165
[No Abstract] [Full Text] [Related]
6. One man at a time--resolving the PSA controversy.
McNaughton-Collins MF; Barry MJ
N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
[No Abstract] [Full Text] [Related]
7. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
Kwiatkowski M; Klotz L; Hugosson J; Recker F
Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
[No Abstract] [Full Text] [Related]
8. Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.
Li J; Berkowitz Z; Hall IJ
J Am Board Fam Med; 2015; 28(4):491-3. PubMed ID: 26152440
[TBL] [Abstract][Full Text] [Related]
9. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
Joshi SS; Filson CP
Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
[No Abstract] [Full Text] [Related]
10. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.
Messing EM; Albertsen P; Andriole GL; Carroll PR; Klein EA
Urol Oncol; 2012; 30(1):117-9. PubMed ID: 22243597
[No Abstract] [Full Text] [Related]
11. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
Eapen RS; Herlemann A; Washington SL; Cooperberg MR
Curr Opin Urol; 2017 May; 27(3):205-209. PubMed ID: 28221220
[TBL] [Abstract][Full Text] [Related]
12. Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.
Rahbar H; Karabon P; Menon M; Trinh QD; Abdollah F
Eur Urol Focus; 2018 Dec; 4(6):1002-1004. PubMed ID: 28753856
[TBL] [Abstract][Full Text] [Related]
13. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
[TBL] [Abstract][Full Text] [Related]
16. US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.
Gejerman G; Ciccone P; Goldstein M; Lanteri V; Schlecker B; Sanzone J; Esposito M; Rome S; Ciccone M; Margolis E; Simon R; Guo Y; Pentakota SR; Sadeghi-Nejad H
Investig Clin Urol; 2017 Nov; 58(6):423-428. PubMed ID: 29124241
[TBL] [Abstract][Full Text] [Related]
17. Psychological research and the prostate-cancer screening controversy.
Arkes HR; Gaissmaier W
Psychol Sci; 2012 Jun; 23(6):547-53. PubMed ID: 22555966
[TBL] [Abstract][Full Text] [Related]
18. Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.
Printz C
Cancer; 2018 Jan; 124(1):11-12. PubMed ID: 29251768
[No Abstract] [Full Text] [Related]
19. The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement.
Turini GA; Gjelsvik A; Renzulli JF
Urology; 2017 Jun; 104():122-130. PubMed ID: 28322897
[TBL] [Abstract][Full Text] [Related]
20. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
